TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Pulmonx Corp (LUNG)

Healthcare Medical Devices
2.10 $
+30.1% vs. previous close
Closing price · As of: 3. Aug 2026

Pulmonx Corp (LUNG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 23 million $. Tick rows to compare them in a chart.

Income Statement LUNG
Tick rows to compare them in a chart (up to 4) Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
18 19 19 21 20 24 23 24 22 23 21 23 87
4.6 5.0 4.9 5.5 5.4 6.2 6.2 6.7 5.5 5.1 4.5 5.0 20
13 14 14 15 15 18 16 17 16 18 16 18 67
4.2 3.9 4.2 5.6 3.7 4.0 4.8 5.3 4.8 4.6 4.9 5.0 19
24 20 24 25 25 19 26 27 26 23 24
28 28 29 31 29 31 31 32 30 27 29 27 114
-15 -14 -15 -16 -14 -13 -15 -15 -14 -9.9 -13 -9.1 -46
0.9 0.9 0.9 0.9 0.9 0.8 0.8 0.8 0.8 0.8 1.0 1.2 3.8
-15 -14 -14 -15 -14 -13 -14 -15 -14 -10 -14 -9.9 -48
0.1 0.2 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.6
-15 -14 -14 -15 -14 -13 -14 -15 -14 -10 -14 -10 -48
-14 -12 -12 -14 -13 -12 -15 -14 -13 -9.2 -12 -8.7 -43

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?